CD4 and neoplasm: On the other hand, the mice injected with Olfr29‐ps1‐overexpressing MDSCs exhibited faster tumor development, larger tumor volume, heavier tumor weight, and fewer CD4+ and CD8+ T cells respect to control mice [162].